Picton Mahoney Asset Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Picton Mahoney Asset Management’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-91,665	Closed	-$9K	–	870
2022 Q2	$9K	Hold	91,665	–	–	﹤0.01%	770
2022 Q1	$19K	Buy	91,665 +49,999	+120%	+$23.4K	﹤0.01%	841
2021 Q4	$26K	Hold	41,666	–	–	﹤0.01%	903
2021 Q3	$25K	Hold	41,666	–	–	﹤0.01%	828
2021 Q2	$39K	Buy	+41,666	New	+$38.8K	﹤0.01%	814

Other funds holding EBACW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Picton Mahoney Asset Management's EBACW Position: Q3 2022 in Review

Picton Mahoney Asset Management sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q3 2022, closing a stake of 91,665 shares — an estimated $9K sold.

Picton Mahoney Asset Management first reported a position in EBACW in Q2 2021 and held it in 5 quarters. The position peaked at $39K in Q2 2021. 29 funds tracked by Wall St. Rank hold EBACW as of Q3 2022.

Picton Mahoney Asset Management reported no remaining European Biotech Acquisition Corp. Warrant position as of Q3 2022 after selling out during the quarter.
Picton Mahoney Asset Management sold 91,665 European Biotech Acquisition Corp. Warrant shares in Q3 2022, an estimated $9K.
Picton Mahoney Asset Management first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 5 quarters.
Picton Mahoney Asset Management's European Biotech Acquisition Corp. Warrant position peaked at $39K in Q2 2021.
29 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q3 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2022, filed 9 Nov 2022.